Investing.com - Medpace Holdings (NASDAQ: MEDP) reported second quarter EPS of $2.75, $0.22 better than the analyst estimate of $2.53. Revenue for the quarter came in at $528.1M versus the consensus estimate of $528.41M.
Guidance
Medpace Holdings sees FY 2024 EPS of $11.24-$11.93 versus the analyst consensus of $11.46.
Medpace Holdings sees FY 2024 revenue of $2.13B-$2.18B versus the analyst consensus of $2.17B.
Medpace Holdings's stock price closed at $437.18. It is up 12.16% in the last 3 months and up 78.11% in the last 12 months.
Medpace Holdings saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Medpace Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Medpace Holdings's Financial Health score is "great performance".
Check out Medpace Holdings's recent earnings performance, and Medpace Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar